Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Cash Equivalents | 830.30 | 250.21 | 357.22 | 218.15 |
Short Term Investments | 160.80 | 550.58 | 303.46 | 739.73 |
Cashand Short Term Investments | 991.10 | 814.31 | 681.66 | 984.03 |
Accounts Receivable- Trade Net | 77.40 | 92.41 | 105.32 | 90.29 |
Total Receivables Net | 78.70 | 95.28 | 108.34 | 92.69 |
Total Inventory | 37.30 | 35.53 | 55.13 | 44.62 |
Other Current Assets Total | 19.60 | 15.17 | 16.13 | 15.66 |
Total Current Assets | 1,126.70 | 973.09 | 875.15 | 1,145.17 |
Property/ Plant/ Equipment Total- Net | 347.00 | 403.97 | 429.82 | 312.01 |
Goodwill Net | 548.20 | 547.84 | 543.44 | 85.36 |
Intangibles Net | 304.30 | 358.19 | 410.56 | 59.51 |
Long Term Investments | 65.40 | - | - | - |
Note Receivable- Long Term | 17.40 | 21.58 | 26.55 | 24.39 |
Other Long Term Assets Total | 47.00 | 80.90 | 61.24 | 34.90 |
Total Assets | 2,456.00 | 2,385.56 | 2,346.75 | 1,661.33 |
Accounts Payable | 186.60 | 156.10 | 147.38 | 144.13 |
Current Portof LT Debt/ Capital Leases | 143.90 | 136.17 | 131.49 | 40.21 |
Other Currentliabilities Total | 134.70 | 107.48 | 125.70 | 89.95 |
Total Current Liabilities | 465.20 | 469.75 | 499.99 | 274.29 |
Long Term Debt | 0.00 | 83.33 | 166.80 | 0.12 |
Capital Lease Obligations | 103.00 | 129.99 | 138.86 | 110.16 |
Total Long Term Debt | 103.00 | 213.32 | 305.66 | 110.28 |
Total Debt | 246.90 | 419.50 | 532.57 | 150.49 |
Deferred Income Tax | 2.40 | 2.94 | 4.04 | 0.76 |
Minority Interest | 36.10 | 33.25 | 35.46 | 30.96 |
Total Liabilities | 606.70 | 719.26 | 845.14 | 416.27 |
Common Stock Total | 83.50 | 83.37 | 83.35 | 83.35 |
Retained Earnings( Accumulated Deficit) | 1,765.80 | 1,501.76 | 1,341.72 | 1,088.98 |
Total Equity | 1,849.30 | 1,666.30 | 1,501.61 | 1,245.06 |
Total Liabilities Shareholders' Equity | 2,456.00 | 2,385.56 | 2,346.75 | 1,661.33 |
Total Common Shares Outstanding | 8.32 | 8.29 | 8.28 | 8.26 |
Tangible Book Valueper Share Common Eq | 119.79 | 91.66 | 66.17 | 133.16 |
Cash | - | 13.52 | 20.97 | 26.15 |
Prepaid Expenses | - | 12.79 | 13.90 | 8.17 |
Property/ Plant/ Equipment Total- Gross | - | 629.71 | 610.06 | 512.05 |
Accumulated Depreciation Total | - | -228.70 | -194.69 | -206.18 |
Notes Payable/ Short Term Debt | - | 70.00 | 95.42 | 0.00 |
Additional Paid- In Capital | - | 93.49 | 92.80 | 92.80 |
Treasury Stock- Common | - | -118.53 | -161.72 | -200.03 |
Other Equity Total | - | -0.46 | -0.08 | -0.06 |
Dr. Lal Pathlabs Dividend Dr. Lal Pathlabs Bonus Dr. Lal Pathlabs News Dr. Lal Pathlabs AGM Dr. Lal Pathlabs Rights Dr. Lal Pathlabs Splits Dr. Lal Pathlabs Board Meetings Dr. Lal Pathlabs Key Metrics Dr. Lal Pathlabs Shareholdings Dr. Lal Pathlabs Profit Loss Dr. Lal Pathlabs Cashflow Dr. Lal Pathlabs Q1 Results Dr. Lal Pathlabs Q2 Results Dr. Lal Pathlabs Q3 Results Dr. Lal Pathlabs Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks